Sylvant Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Sylvant General Information
Description
A monoclonal antibody medicine used to treat people with Multicentric Castleman's Disease (MCD). The drug blocks the action of interleukin-6 (IL-6), a multifunctional cytokine detected at elevated levels in patients with Idiopathic MCD (iMCD), an inflammatory lymphoproliferative disorder that causes the abnormal overgrowth of immune cells and shares many symptomatic.
Contact Information
Website
www.sylvant.comCorporate Office
- PO Box 200
- Titusville, NJ
- United States
Corporate Office
- PO Box 200
- Titusville, NJ
- United States
Sylvant Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sylvant Patents
Sylvant Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015077966-A1 | Crystal form of nucleoside inhibitor of hcv | Inactive | 28-Nov-2013 | ||
| WO-2015059212-A1 | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | Inactive | 23-Oct-2013 | ||
| WO-2015014836-A1 | Substituted pyridine-piperazinyl analogues as rsv antiviral compounds | Inactive | 30-Jul-2013 | ||
| WO-2015014815-A1 | Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections | Inactive | 30-Jul-2013 | ||
| WO-2015011281-A1 | Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | Inactive | 25-Jul-2013 | C07D207/34 |
Sylvant Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sylvant FAQs
-
Where is Sylvant headquartered?
Sylvant is headquartered in Titusville, NJ.
-
What industry is Sylvant in?
Sylvant’s primary industry is Buildings and Property.
-
Is Sylvant a private or public company?
Sylvant is a Private company.
-
What is the current valuation of Sylvant?
The current valuation of Sylvant is .
-
What is Sylvant’s current revenue?
The current revenue for Sylvant is .
-
Who are Sylvant’s investors?
Johnson&Johnson Innovative Medicine has invested in Sylvant.
-
When was Sylvant acquired?
Sylvant was acquired on 01-Jul-2018.
-
Who acquired Sylvant?
Sylvant was acquired by EUSA Pharma (UK).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process